Background: Multidisciplinary teamwork is considered central to pediatric palliative care. Although different studies state that volunteers play an essential role in palliative care, little is known about the collaboration between volunteers and staff.
Aim: This study aims to explore and compare the perspectives of volunteers and staff regarding collaboration in a pediatric palliative care unit.
Design: A mixed-methods approach was chosen to appropriately reflect the complex aspects of collaboration.
Setting/participants: Both face-to-face interviews with staff who work together with volunteers and a group discussion with all volunteers were conducted. These were supplemented by 2 questionnaires designed for this study that examined participants' characteristics and their estimation of what information volunteers need before they meet a patient.
Results: Nine staff members and 7 volunteers participated in this study. Their ideas of collaboration could be grouped into 3 categories: (i) factual level of collaboration, (ii) relationship level of collaboration, and (iii) overall appraisal of collaboration (suggestions for improvement).
Conclusion: Communication can be considered a key factor in successful collaboration between volunteers and staff. Because many patients in pediatric palliative care units are not able to communicate verbally, good information flow between volunteers and staff is crucial for ensuring quality patient care. Moreover, communication is the key to establishing a team philosophy by clarifying roles and building relationships between volunteers and staff.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1049909117751419 | DOI Listing |
BMC Health Serv Res
December 2024
Fountain Africa Trust CBO, Webuye, Kenya.
Background: Both unintended pregnancy and unsafe abortion are major public health problems in Kenya. The World Health Organization recommends the use of medication abortion to stop unwanted pregnancies. However, the extent of provision and uptake of medication abortion through private pharmacies in Kenya is not well known.
View Article and Find Full Text PDFBMC Public Health
December 2024
Department of Microbiology, Immunology, and Infectious Diseases, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
Background: Understanding awareness of antibiotics is crucial in identifying the attitudes of people which could subsequently help shape campaigns and policies addressing this problem. The study aimed to explore awareness of antibiotics use and antibiotic resistance among faculty and staff at the medical institution.
Methodology: All the study participants (faculty & staff) were asked to complete the survey.
Ann Work Expo Health
December 2024
HSE Science Division, Health and Safety Executive's Science and Research Centre, Harpur Hill, Buxton SK17 9JN, United Kingdom.
Desktop three-dimensional (3D) printers are used in businesses, schools, and colleges, and are generally of an unenclosed design which may give rise to injuries or inhalation exposure to emissions of small particles (<1 µm) and volatile organic compounds (VOCs). The aim of this work was to explore the health risks related to the use of desktop 3D printers in workplaces in the United Kingdom. A digital survey on the use of desktop 3D printers was completed voluntarily and anonymously between February and June 2023, receiving 146 responses.
View Article and Find Full Text PDFBMC Health Serv Res
December 2024
Clinic for Emergency Medicine, Ketteler Krankenhaus gGmbH, Offenbach Hesse, Germany.
Background: A large number of people in Germany have no health insurance. Their access to the official healthcare system is significantly more difficult or impossible. Charitable institutions try to provide medical care and create parallel healthcare structures.
View Article and Find Full Text PDFLancet Infect Dis
December 2024
MMV Medicines for Malaria Venture, Geneva, Switzerland.
Background: Novel antimalarials are needed to address emerging resistance to artemisinin and partner drugs. We did two trials to evaluate safety, tolerability, pharmacokinetics, and activity against blood stage Plasmodium falciparum for the drug candidate MMV533.
Methods: A phase 1a first-in-human (FIH) trial was conducted at Nucleus Network (Melbourne, VIC, Australia).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!